Rick E Winningham's Net Worth

$73.4 Million

Estimate Recalculated Sep 11, 2024 10:39AM EST

Who is Rick E Winningham?

Rick E Winningham has an estimated net worth of $73.4 Million. This is based on reported shares across multiple companies, which include THERAVANCE INC, Theravance Biopharma, Inc., JAZZ PHARMACEUTICALS INC, and OncoMed Pharmaceuticals Inc.

SEC CIK

Rick E Winningham's CIK is 0001302443

Past Insider Trading and Trends

2012 was Rick E Winningham's most active year for acquiring shares with 12 total transactions. Rick E Winningham's most active month to acquire stocks was the month of July. 2011 was Rick E Winningham's most active year for disposing of shares, totalling 19 transactions. Rick E Winningham's most active month to dispose stocks was the month of July. 2013 saw Rick E Winningham paying a total of $3,731,247.19 for 413,911 shares, this is the most they've acquired in one year. In 2013 Rick E Winningham cashed out on 704,909 shares for a total of $10,913,052.93, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

THERAVANCE INC (INVA) Snapshot price: $18.7201

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.44%
-96.25K
—
—
825.39K
Aug 15
Form 4
+7.26%
62.4K
—
—
921.64K
Jun 16
Form 4
+22.22%
156.2K
—
—
859.24K
Jun 2
Form 4
-6.67%
-50.23K
$26.86
-$1,349,043.50
703.04K
May 9
Form 4
+12.30%
82.5K
—
—
753.26K
Apr 27
Form 4
-1.37%
-9.30K
$39.98
-$371,694.06
670.76K
Feb 20
Form 4
-1.46%
-10.05K
$36.40
-$365,674.40
680.06K
Nov 20
Form 4
-3.14%
-22.35K
$40.03
-$894,790.59
690.11K
Scheduled
Sep 12
Form 4
-1.39%
-10.05K
$35.89
-$360,550.94
712.46K
Aug 20
Form 4
+1.55%
11K
—
—
722.5K
Jul 24
Form 4
-1.39%
-10.05K
$37.01
-$371,802.46
711.5K
May 20
Form 4
+21.90%
129.63K
$21.67
-$4,865,921.65
721.55K
Scheduled
Apr 30
Form 4
-1.77%
-10.65K
$22.10
-$235,475.50
591.92K
Feb 20
Form 4
+1.86%
11K
—
—
602.58K
Feb 7
Form 4
+1.89%
11K
—
—
591.58K
Oct 15
Form 4
-1.81%
-10.68K
$27.01
-$288,493.81
580.58K
Aug 20
Form 4
+13.30%
69.41K
$15.53
-$1,667,306.63
591.26K
Scheduled
Aug 3
Form 4
-2.01%
-10.68K
$20.33
-$217,144.73
521.85K
May 20
Form 4
+13.47%
63.23K
$6.33
$400,070.03
532.53K
May 4
Form 4
-4.36%
-21.39K
$18.54
-$396,496.44
469.3K
Feb 20
Form 4
+2.29%
11K
—
—
490.69K
Feb 15
Form 4
-1.28%
-6.22K
$22.34
-$138,910.12
479.69K
Nov 20
Form 4
-20.82%
-127.75K
$26.34
-$3,364,268.86
485.91K
Scheduled
May 10 - May 11
Form 4
-9.43%
-63.87K
$22.53
-$1,439,058.69
613.65K
Scheduled
Mar 1
Form 4
+21.80%
121.25K
$15.38
-$2,427,018.20
677.52K
Scheduled
Feb 24 - Feb 28
Form 4
+29.72%
127.45K
$14.95
-$2,425,383.00
556.27K
Scheduled
Feb 20 - Feb 23
Form 4
+136.50%
247.5K
—
—
428.82K
Feb 11
Form 4
-2.97%
-5.55K
$22.52
-$125,098.60
181.32K
Nov 20
Form 4
+17.25%
27.5K
—
—
186.88K
Oct 26
Form 4
-2.22%
-3.62K
$14.00
-$50,736.00
159.38K
Aug 20
Form 4
-2.18%
-3.63K
$13.02
-$47,197.50
163K
May 20
Form 4
-1.43%
-2.41K
$10.22
-$24,660.86
166.63K
Feb 20
Form 4
+48.23%
55K
—
—
169.04K
Feb 10
Form 4
-2.03%
-2.36K
$14.04
-$33,190.56
114.04K
Nov 20
Form 4
-1.94%
-2.30K
$15.65
-$36,041.95
116.4K
Aug 20
Form 4
-1.90%
-2.30K
$14.06
-$32,380.18
118.71K
May 20
Form 4
+195.07%
80K
—
—
121.01K
Mar 20
Form 4
-4.89%
-2.11K
$14.87
-$31,345.96
41.01K
Feb 20
Form 4
+86.51%
20K
$10.47
$209,420.98
43.12K
Mar 11
Form 4
∞
23.12K
—
—
23.12K
Jan 29
Form 4
—
0
—
—
0
Apr 25
Form 4
—
0
—
—
0
Feb 8
Form 3
—
0
—
—
0
No matching records found

Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01

CHIEF EXECUTIVE OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.87%
-16.00K
$8.22
-$131,495.34
1.82M
Aug 20
Form 4
+0.18%
3.25K
$7.83
$25,463.16
1.84M
Aug 7
Form 4
-0.86%
-16.00K
$9.10
-$145,572.70
1.84M
May 20
Form 4
+0.11%
2.07K
$9.85
$20,369.80
1.85M
May 15
Form 4
+19.35%
300K
—
—
1.85M
Apr 2
Form 4
-0.28%
-4.30K
$8.64
$23,362.56
1.55M
Mar 15
Form 4
-2.33%
-37.20K
$8.92
-$331,788.32
1.56M
Feb 20
Form 4
-0.98%
-15.80K
$10.37
-$163,887.48
1.6M
Nov 20
Form 4
-0.97%
-15.80K
$9.70
-$153,298.80
1.61M
Aug 20
Form 4
-0.96%
-15.80K
$11.21
-$177,162.84
1.63M
May 20
Form 4
+25.13%
330K
—
—
1.64M
Mar 1
Form 4
-2.77%
-37.42K
$10.44
-$390,664.80
1.31M
Feb 20
Form 4
-4.18%
-59.00K
$11.19
—
1.35M
Dec 13 - Dec 14
Form 4
-1.11%
-15.80K
$10.85
-$171,473.40
1.41M
Nov 20
Form 4
-1.10%
-15.80K
$9.34
-$147,609.36
1.42M
Aug 19
Form 4
-0.76%
-11.03K
$8.74
-$96,358.50
1.44M
May 20
Form 4
+13.29%
170K
—
—
1.45M
Feb 25
Form 4
-1.74%
-22.71K
$9.61
-$218,243.10
1.28M
Feb 18
Form 4
-0.87%
-11.40K
$8.36
-$95,337.44
1.3M
Nov 19
Form 4
-0.86%
-11.40K
$14.05
-$160,226.20
1.31M
Aug 20
Form 4
-0.85%
-11.40K
$17.80
-$202,991.20
1.32M
May 20
Form 4
-7.64%
-110.35K
$18.79
-$2,073,438.92
1.33M
Feb 20
Form 4
+13.33%
170K
—
—
1.45M
Feb 8
Form 4
-1.08%
-13.95K
$17.21
-$240,010.66
1.28M
Nov 20
Form 4
-1.07%
-13.95K
$18.22
-$254,096.12
1.29M
Aug 20
Form 4
-1.06%
-13.95K
$26.67
-$371,939.82
1.3M
May 20
Form 4
-6.86%
-96.85K
$25.90
-$2,508,415.00
1.32M
Feb 20
Form 4
+31.46%
338K
—
—
1.41M
Feb 3
Form 4
-0.80%
-8.68K
$17.60
-$152,732.80
1.07M
Nov 20
Form 4
-0.79%
-8.68K
$21.51
-$186,663.78
1.08M
Aug 20
Form 4
-0.79%
-8.68K
$19.84
-$172,171.52
1.09M
May 20
Form 4
-1.21%
-13.48K
$27.00
-$363,879.00
1.1M
Feb 20
Form 4
+39.83%
317K
—
—
1.11M
Feb 5
Form 4
-1.92%
-15.56K
$24.79
-$385,658.03
795.94K
Nov 20
Form 4
-1.69%
-15.56K
$26.95
-$419,261.15
904.06K
Aug 20
Form 4
-6.85%
-67.62K
$24.31
-$1,643,769.27
919.62K
May 20
Form 4
+11.90%
105K
—
—
987.24K
May 14
Form 4
-1.45%
-13.01K
$29.09
-$378,315.45
881.37K
Feb 20
Form 4
+3.23%
28K
—
—
894.38K
Feb 12
Form 4
+1.17%
10K
$24.50
$245,000.00
866.38K
Aug 11
Form 4
-1.77%
-15.46K
$36.83
-$569,391.80
856.38K
May 20
Form 4
-3.68%
-33.26K
$33.78
-$1,123,657.92
870.13K
Feb 20
Form 4
+3.20%
28K
—
—
903.4K
Feb 6
Form 4
-0.95%
-8.36K
$31.96
-$267,185.60
875.4K
Nov 20
Form 4
+46.51%
280K
—
—
882.06K
Mar 15
Form 4
+7.24%
80K
$11.96
$948,932.40
1.19M
Aug 14 - Aug 17
Form 4
-0.28%
-1.48K
$19.52
-$28,889.60
520.16K
Feb 20
Form 4
+92.07%
250.06K
—
—
521.64K
Aug 20 - Feb 5
Form 4
—
0
—
—
0
Aug 22
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found

Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+21.30%
1.83K
$138.16
-$171,454.57
10.44K
Aug 11 - Aug 14
Form 4
+20.62%
1.47K
$152.32
-$165,879.31
8.61K
Aug 5 - Aug 8
Form 4
-15.47%
-1.31K
$147.96
-$193,235.76
7.14K
Aug 6
Form 4
+36.24%
2.25K
—
—
8.44K
Jul 29
Form 4
+40.10%
1.77K
$125.87
-$117,184.88
6.2K
Aug 6 - Aug 7
Form 4
+36.97%
1.19K
$135.65
-$98,482.19
4.42K
Aug 8 - Aug 9
Form 4
-55.38%
-6.14K
$120.24
-$2,352,745.75
4.95K
Aug 9 - Aug 10
Form 4
+6.77%
703
$142.37
-$94,247.89
11.09K
Aug 10 - Aug 11
Form 4
-32.49%
-5.00K
$150.00
-$750,000.00
10.39K
Jun 1
Form 4
-3.95%
-633.00
$136.45
-$86,372.85
15.39K
Aug 15
Form 4
+9.31%
1.36K
—
—
16.02K
Aug 11
Form 4
+3.60%
509
$180.00
-$144,177.51
14.66K
Aug 7 - Aug 10
Form 4
-7.13%
-1.09K
$133.15
-$144,734.05
14.15K
Aug 12
Form 4
+12.14%
1.65K
—
—
15.24K
Aug 7
Form 4
-66.93%
-27.50K
$140.00
-$3,850,000.00
13.59K
Scheduled
Apr 17
Form 4
-2.54%
-1.07K
$81.86
-$87,590.20
41.09K
Aug 13
Form 4
+5.64%
2.25K
—
—
42.16K
Aug 8
Form 4
+5.97%
2.25K
—
—
39.91K
Aug 9
Form 4
∞
37.66K
—
—
37.66K
Jan 18
Form 3
—
0
—
—
0
Form 4
-100.00%
-37.66K
—
—
0
Jan 18
Form 4
∞
37.66K
$31.97
$80.20
37.66K
Jan 11
Form 4
—
0
—
—
0
Nov 4
Form 4
—
0
—
—
0
Aug 25
Form 4
—
0
—
—
0
May 4
Form 3
—
0
—
—
0
No matching records found

OncoMed Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found